Fu R, Tajima S, Shigematsu T, Zhang M, Tsuchimoto A, Egashira N, Ieiri I & Masuda S: Establishment of an experimental rat model of tacrolimus-induced kidney injury accompanied by interstitial fibrosis. Toxicol Lett, 341): 43-50 (2021) doi:10.1016/j.toxlet.2021.01.020.
Matsukane R, Watanabe H, Minami H, Hata K, Suetsugu K, Tsuji T, Masuda S, Okamoto I, Nakagawa T, Ito T, Eto M, Mori M, Nakanishi Y & Egashira N: Continuous monitoring of neutrophils to lymphocytes ratio for estimating the onset, severity, and subsequent prognosis of immune related adverse events. Sci Rep, 11 (1): 1324 (2021) doi:10.1038/s41598-020-79397-6.
Zhang M, Tajima S, Shigematsu T, Fu R, Noguchi H, Kaku K, Tsuchimoto A, Okabe Y, Egashira N & Masuda S: Donor CYP3A5 Gene Polymorphism Alone Cannot Predict Tacrolimus Intrarenal Concentration in Renal Transplant Recipients. Int J Mol Sci, 21 (8): E2986 (2020) doi:10.3390/ijms21082976.
Yamamoto Y, Nakase H, Matsuura M, Maruyama S & Masuda S: CYP3A5 Genotype as a Potential Pharmacodynamic Biomarker for Tacrolimus Therapy in Ulcerative Colitis in Japanese Patients. Int J Mol Sci, 21 (12): E4347 (2020) doi:10.3390/ijms21124347.
Yamada T, Zhang M & Masuda S: Significance of Ethnic Factors in Immunosuppressive Therapy Management After Organ Transplantation. Ther Drug Monit, 42 (3): 369-380 (2020) doi:10.1097/ftd.0000000000000748.
Tanihara Y, Masuda S & Inui KI: Inhibitory effects of vandetanib on creatinine transport via renal organic cation transporter OCT2. Eur J Pharm Sci, 158): 105666 (2020) doi:10.1016/j.ejps.2020.105666.
Shigematsu T, Suetsugu K, Yamamoto N, Tsuchiya Y & Masuda S: Comparison of 4 Commercial Immunoassays Used in Measuring the Concentration of Tacrolimus in Blood and Their Cross-Reactivity to Its Metabolites. Ther Drug Monit, 42 (3): 400-406 (2020) doi:10.1097/ftd.0000000000000696.
Nakamura T, Fukuda M, Matsukane R, Suetsugu K, Harada N, Yoshizumi T, Egashira N, Mori M & Masuda S: Influence of POR*28 Polymorphisms on CYP3A5*3-Associated Variations in Tacrolimus Blood Levels at an Early Stage after Liver Transplantation. Int J Mol Sci, 21 (7): E2287 (2020) doi:10.3390/ijms21072287.
Mei T, Noguchi H, Suetsugu K, Hisadome Y, Kaku K, Okabe Y, Masuda S & Nakamura M: Effects of Concomitant Administration of Vonoprazan Fumarate on the Tacrolimus Blood Concentration in Kidney Transplant Recipients. Biol Pharm Bull, 43 (10): 1600-1603 (2020) doi:10.1248/bpb.b20-00361.
Kajinami K, Tsukamoto K, Koba S, Inoue I, Yamakawa M, Suzuki S, Hamano T, Saito H, Saito Y, Masuda S, Nakayama T, Okamura T, Yamashita S, Kagawa T, Kaneyama J, Kuriyama A, Tanaka R & Hirata A: Statin Intolerance Clinical Guide 2018. J Atheroscler Thromb, 27): 375-396 (2020) doi:10.5551/jat.50948.
Ishida S, Morikawa H, Watanabe H, Tsuji T, Sugio T, Mori Y, Miyamoto T, Masuda S, Akashi K & Egashira N: Increasing Diluent Volume Decreases Bendamustine-Induced Venous Irritation without Reducing the Therapeutic Efficacy. Biol Pharm Bull, 43 (3): 488-492 (2020) doi:10.1248/bpb.b19-00826.
Ishida S, Masuguchi K, Kawashiri T, Tsuji T, Watanabe H, Akiyoshi S, Kubo M, Masuda S & Egashira N: Effects of Diluent Volume and Administration Time on the Incidence of Anaphylaxis Following Docetaxel Therapy in Breast Cancer. Biol Pharm Bull, 43 (4): 663-668 (2020) doi:10.1248/bpb.b19-00876.
Hata K, Suetsugu K, Egashira N, Makihara Y, Itoh S, Yoshizumi T, Tanaka M, Kohjima M, Watanabe H, Masuda S & Ieiri I: Association of lenvatinib plasma concentration with clinical efficacy and adverse events in patients with hepatocellular carcinoma. Cancer Chemother Pharmacol, 86 (6): 803-813 (2020) doi:10.1007/s00280-020-04178-x.
Harada N, Yoshizumi T, Yoshiya S, Takeishi K, Toshima T, Itoh S, Ikegami T, Fukuda M, Masuda S & Mori M: Use of Mycophenolate Mofetil Suspension as Part of Induction Therapy After Living-Donor Liver Transplant. Exp Clin Transplant, 18 (4): 485-490 (2020) doi:10.6002/ect.2020.0041.
Zhang W, Egashira N & Masuda S: Recent Topics on The Mechanisms of Immunosuppressive Therapy-Related Neurotoxicities. Int J Mol Sci, 20 (13): E3210 (2019) doi:10.3390/ijms20133210.
Yoneshima Y, Tanaka K, Shiraishi Y, Hata K, Watanabe H, Harada T, Otsubo K, Iwama E, Inoue H, Masuda S, Nakanishi Y & Okamoto I: Safety and efficacy of PD-1 inhibitors in non-small cell lung cancer patients positive for antinuclear antibodies. Lung Cancer, 130): 5-9 (2019) doi:10.1016/j.lungcan.2019.01.014.
Yamamoto Y, Masuda S, Nakase H, Matsuura M, Maruyama S, Hisamatsu T, Suzuki Y & Matsubara K: Influence of Pharmaceutical Formulation on the Mucosal Concentration of 5-Aminosalicylic Acid and N-Acetylmesalamine in Japanese Patients with Ulcerative Colitis. Biol Pharm Bull, 42 (1): 81-86 (2019) doi:10.1248/bpb.b18-00561.
Watanabe H, Uchida M & Masuda S: [Clinical Pharmacology Research for Promoting Individualized Cancer Chemotherapy]. Yakugaku Zasshi, 139 (6): 901-909 (2019) doi:10.1248/yakushi.18-00213-1.
Uchida M, Nakamura T, Watanabe H, Kato K, Miyamoto T, Akashi K & Masuda S: Usefulness of medication instruction sheets for sharing information on cancer chemotherapy within the health care team. Pharmazie, 74 (9): 566-569 (2019) doi:10.1691/ph.2019.9467.
Tsuchiya Y, Suetsugu K, Yamamoto N, Kobayashi D, Tsuji T, Watanabe H, Egashira N & Masuda S: Simultaneous determination of plasma concentration of 12 oral molecular-targeted drugs by ultra-performance liquid chromatography-tandem mass spectrometry. Jap J Ther Drug Monit, 36 (3): 105-116 (2019)
Tajima S, Yamamoto N & Masuda S: Clinical prospects of biomarkers for the early detection and/or prediction of organ injury associated with pharmacotherapy. Biochemical Pharmacology, 170): 113664 (2019) doi:https://doi.org/10.1016/j.bcp.2019.113664.
Tajima S, Fu R, Shigematsu T, Noguchi H, Kaku K, Tsuchimoto A, Okabe Y & Masuda S: Urinary Human Epididymis Secretory Protein 4 as a Useful Biomarker for Subclinical Acute Rejection Three Months after Kidney Transplantation. Int J Mol Sci, 20 (19): E4699 (2019) doi:10.3390/ijms20194699.
Suetsugu K, Mori Y, Yamamoto N, Shigematsu T, Miyamoto T, Egashira N, Akashi K & Masuda S: Impact of CYP3A5, POR, and CYP2C19 Polymorphisms on Trough Concentration to Dose Ratio of Tacrolimus in Allogeneic Hematopoietic Stem Cell Transplantation. Int J Mol Sci, 20 (10): W2413 (2019) doi:10.3390/ijms20102413.
Saito M, Chen-Yoshikawa TF, Suetsugu K, Okabe R, Takahagi A, Masuda S & Date H: Pirfenidone alleviates lung ischemia-reperfusion injury in a rat model. J Thorac Cardiovasc Surg, 158 (1): 289-296 (2019) doi:10.1016/j.jtcvs.2018.08.098.
Fukuda M, Suetsugu K, Tajima S, Katsube Y, Watanabe H, Harada N, Yoshizumi T, Egashira N, Mori M & Masuda S: Neutrophil Gelatinase-Associated Lipocalin Is Not Associated with Tacrolimus-Induced Acute Kidney Injury in Liver Transplant Patients Who Received Mycophenolate Mofetil with Delayed Introduction of Tacrolimus. Int J Mol Sci, 20 (12): E3103 (2019) doi:10.3390/ijms20123103.
Fu R, Tajima S, Suetsugu K, Watanabe H, Egashira N & Masuda S: Biomarkers for individualized dosage adjustments in immunosuppressive therapy using calcineurin inhibitors after organ transplantation. Acta Pharmacol Sin, 40 (2): 151-159 (2019) doi:10.1038/s41401-018-0070-2.
Brunet M, van Gelder T, Asberg A, Haufroid V, Hesselink DA, Langman L, Lemaitre F, Marquet P, Seger C, Shipkova M, Vinks A, Wallemacq P, Wieland E, Woillard JB, Barten MJ, Budde K, Colom H, Dieterlen MT, Elens L, Johnson-Davis KL, Kunicki PK, MacPhee I, Masuda S, Mathew BS, Millan O, Mizuno T, Moes DAR, Monchaud C, Noceti O, Pawinski T, Picard N, van Schaik R, Sommerer C, Vethe NT, de Winter B, Christians U & Bergan S: Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report. Ther Drug Monit, 41 (3): 261-307 (2019) doi:10.1097/ftd.0000000000000640.
Yamamoto S, Egashira N, Tsuda M & Masuda S: Riluzole prevents oxaliplatin-induced cold allodynia via inhibition of overexpression of transient receptor potential melastatin 8 in rats. J Pharmacol Sci, 138 (3): 214-217 (2018) doi:10.1016/j.jphs.2018.10.006.
Tanioka H, Miyamoto Y, Tsuji A, Asayama M, Shiraishi T, Yuki S, Kotaka M, Makiyama A, Shimokawa M, Shimose T, Masuda S, Yamaguchi T, Komatsu Y, Saeki H, Emi Y, Baba H, Oki E & Maehara Y: Prophylactic Effect of Dexamethasone on Regorafenib-Related Fatigue and/or Malaise: A Randomized, Placebo-Controlled, Double-Blind Clinical Study in Patients with Unresectable Metastatic Colorectal Cancer (KSCC1402/HGCSG1402). Oncology, 94 (5): 289-296 (2018) doi:10.1159/000486624.
Iwasaki M, Yano I, Fukatsu S, Hashi S, Yamamoto Y, Sugimoto M, Fukudo M, Masuda S, Nakagawa S, Yonezawa A, Kaido T, Uemoto S & Matsubara K: Pharmacokinetics and Pharmacodynamics of Once-Daily Tacrolimus Compared With Twice-Daily Tacrolimus in the Early Stage After Living Donor Liver Transplantation. Ther Drug Monit, 40 (6): 675-681 (2018) doi:10.1097/ftd.0000000000000551.
Yamamoto S, Ushio S, Egashira N, Kawashiri T, Mitsuyasu S, Higuchi H, Ozawa N, Masuguchi K, Ono Y & Masuda S: Excessive spinal glutamate transmission is involved in oxaliplatin-induced mechanical allodynia: a possibility for riluzole as a prophylactic drug. Sci Rep, 7 (1): 9661 (2017) doi:10.1038/s41598-017-08891-1.
Yamada T, Kubota T, Yonezawa M, Nishio H, Kanno S, Yano T, Kobayashi D, Egashira N, Takada H, Hara T & Masuda S: Evaluation of Teicoplanin Trough Values After the Recommended Loading Dose in Children With Associated Safety Analysis. Pediatr Infect Dis J, 36 (4): 398-400 (2017) doi:10.1097/inf.0000000000001456.
Suetsugu K, Ikesue H, Miyamoto T, Shiratsuchi M, Yamamoto-Taguchi N, Tsuchiya Y, Matsukawa K, Uchida M, Watanabe H, Akashi K & Masuda S: Analysis of the variable factors influencing tacrolimus blood concentration during the switch from continuous intravenous infusion to oral administration after allogeneic hematopoietic stem cell transplantation. Int J Hematol, 105 (3): 361-368 (2017) doi:10.1007/s12185-016-2135-7.
Sakamoto Y, Yano T, Hanada Y, Takeshita A, Inagaki F, Masuda S, Matsunaga N, Koyanagi S & Ohdo S: Vancomycin induces reactive oxygen species-dependent apoptosis via mitochondrial cardiolipin peroxidation in renal tubular epithelial cells. Eur J Pharmacol, 800): 48-56 (2017) doi:10.1016/j.ejphar.2017.02.025.
Murata K, Motomura Y, Tanaka T, Kanno S, Yano T, Onimaru M, Shimoyama A, Nishio H, Sakai Y, Oh-Hora M, Hara H, Fukase K, Takada H, Masuda S, Ohga S, Yamasaki S & Hara T: Calcineurin inhibitors exacerbate coronary arteritis via the MyD88 signaling pathway in a murine model of Kawasaki disease. Clin Exp Immunol, 190 (1): 54-67 (2017) doi:10.1111/cei.13002.
Yoshimatsu H, Yonezawa A, Yamanishi K, Yao Y, Sugano K, Nakagawa S, Imai S, Omura T, Nakagawa T, Yano I, Masuda S, Inui K & Matsubara K: Disruption of Slc52a3 gene causes neonatal lethality with riboflavin deficiency in mice. Sci Rep, 6): 27557 (2016) doi:10.1038/srep27557.
Yamada T, Ueda M, Egashira N, Zukeyama N, Kuwahara J & Masuda S: Involvement of intracellular cAMP in epirubicin-induced vascular endothelial cell injury. J Pharmacol Sci, 130 (1): 33-37 (2016) doi:10.1016/j.jphs.2015.12.010.
Yahata H, Kobayashi H, Sonoda K, Shimokawa M, Ohgami T, Saito T, Ogawa S, Sakai K, Ichinoe A, Ueoka Y, Hasuo Y, Nishida M, Masuda S & Kato K: Efficacy of aprepitant for the prevention of chemotherapy-induced nausea and vomiting with a moderately emetogenic chemotherapy regimen: a multicenter, placebo-controlled, double-blind, randomized study in patients with gynecologic cancer receiving paclitaxel and carboplatin. Int J Clin Oncol, 21 (3): 491-497 (2016) doi:10.1007/s10147-015-0928-y.
Watanabe H, Nishibatake Y, Hata K, Makihara Y, Nakanishi Y & Masuda S: Elevated Prothrombin Time/International Normalized Ratio after Concomitant Administration of Erlotinib in Patients Receiving Warfarin: A Report on Two Cases. Ann Clin Case Rep, 1): 1210 (2016) doi:http://anncaserep.com/pdfs_folder/accr-v1-id1210.pdf.
Tsuji T, Nagata K, Kawashiri T, Yamada T, Irisa T, Murakami Y, Kanaya A, Egashira N & Masuda S: The Relationship between Occurrence Timing of Dispensing Errors and Subsequent Danger to Patients under the Situation According to the Classification of Drugs by Efficacy. Yakugaku Zasshi, 136 (11): 1573-1584 (2016) doi:10.1248/yakushi.16-00175.
Tanaka S, Chen-Yoshikawa TF, Kajiwara M, Menju T, Ohata K, Takahashi M, Kondo T, Hijiya K, Motoyama H, Aoyama A, Masuda S & Date H: Protective Effects of Imatinib on Ischemia/Reperfusion Injury in Rat Lung. Ann Thorac Surg, 102 (5): 1717-1724 (2016) doi:10.1016/j.athoracsur.2016.05.037.
Tanaka A, Yano I, Shinsako K, Sato E, Fukudo M, Masuda S, Yamasaki T, Kamba T, Ogawa O & Matsubara K: Population Pharmacokinetics of Everolimus in Relation to Clinical Outcomes in Patients With Advanced Renal Cell Carcinoma. Ther Drug Monit, 38 (6): 663-669 (2016) doi:10.1097/ftd.0000000000000344.
Shipkova M, Hesselink DA, Holt DW, Billaud EM, van Gelder T, Kunicki PK, Brunet M, Budde K, Barten MJ, De Simone P, Wieland E, Lopez OM, Masuda S, Seger C, Picard N, Oellerich M, Langman LJ, Wallemacq P, Morris RG, Thompson C & Marquet P: Therapeutic Drug Monitoring of Everolimus: A Consensus Report. Ther Drug Monit, 38 (2): 143-169 (2016) doi:10.1097/ftd.0000000000000260.
Onoue H, Yano I, Tanaka A, Itohara K, Hanai A, Ishiguro H, Motohashi H, Masuda S & Matsubara K: Significant effect of age on docetaxel pharmacokinetics in Japanese female breast cancer patients by using the population modeling approach. Eur J Clin Pharmacol, 72 (6): 703-710 (2016) doi:10.1007/s00228-016-2031-3.
Miura M, Masuda S, Egawa H, Yuzawa K & Matsubara K: Inter-laboratory Variability of Current Immunoassay Methods for Tacrolimus Among Japanese Hospitals. Biol Pharm Bull, 39 (8): 1331-1337 (2016) doi:10.1248/bpb.b16-00249.
Kamei H, Masuda S, Ishigami M, Nakamura T, Fujimoto Y, Takada Y & Hamajima N: Association of interleukin4 gene polymorphisms of recipients and donors with acute rejection following living donor liver transplantation. Clin Res Hepatol Gastroenterol, 40 (2): 179-185 (2016) doi:10.1016/j.clinre.2015.06.019.
Kajiwara M & Masuda S: Role of mTOR Inhibitors in Kidney Disease. Int J Mol Sci, 17 (6): E975 (2016) doi:10.3390/ijms17060975.
Kajiwara M, Ban T, Matsubara K, Nakanishi Y & Masuda S: Urinary Dopamine as a Potential Index of the Transport Activity of Multidrug and Toxin Extrusion in the Kidney. Int J Mol Sci, 17 (8): E1228 (2016) doi:10.3390/ijms17081228.